Abstract
Brostallicin, a specific adenine-thymine minor groove binder belonging to a new class of distamycin A-derivatives, proved to be active in vitro against a panel of human tumor cell lines. We demonstrated here the cytotoxic and apoptotic potential of this compound on gastric and colon cancer cell lines with either wt or mutated p53.
Keywords: Apoptosis, Brostallicin, Colon carcinoma cell lines, Gastric cancer cell lines, p53
Article Metrics
1